Green tea attenuates oxidative stress and downregulates the expression of angiotensin II ATreceptor in renal and hepatic tissues of streptozotocin-induced diabetic rats

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Thomson, Martha ^a   Al Qattan, Khaled ^a   Mansour, Mohamed H ^a   Ali, Muslim ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANTIOXIDANT; CATALASE; GLUCOSE; GREEN TEA EXTRACT; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KIDNEY PARENCHYMA; LIVER; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

EID: 84871367277     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/409047     Document Type: Article

References (55)

1. Weisburger J. H., Tea and health: a historical perspective. Cancer Letters 1997 114 1-2 315 317 2-s2.0-0030980542 10.1016/S0304-3835(97)04691-0 (Pubitemid 27140141)
2. Chen N., Bezzina R., Hinch E., Lewandowski P. A., Cameron-Smith D., Mathai M. L., Jois M., Sinclair A. J., Begg D. P., Wark J. D., Weisinger H. S., Weisinger R. S., Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutrition Research 2009 29 11 784 793 2-s2.0-70449675075 10.1016/j.nutres.2009.10.003
3. Hodgson J. M., Croft K. D., Tea flavonoids and cardiovascular health. Molecular Aspects of Medicine 2010 31 6 495 502 2-s2.0-78649635378 10.1016/j.mam.2010.09.004
4. Clement Y., Can green tea do that? A literature review of the clinical evidence. Preventive Medicine 2009 49 2-3 83 87 2-s2.0-70349272189 10.1016/j.ypmed.2009.05.005
5. Chacko S. M., Thambi P. T., Kuttan R., Nishigaki I., Beneficial effects of green tea: a literature review. Chinese Medicine 2010 5, article 13 2-s2.0-77950529178 10.1186/1749-8546-5-13
6. Guo Q., Zhao B., Li M., Shen S., Wenjuan X., Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochimica et Biophysica Acta 1996 1304 3 210 222 2-s2.0-0030582664 10.1016/S0005-2760(96)00122-1 (Pubitemid 26426992)
7. Tsuneki H., Ishizuka M., Terasawa M., Wu J. B., Sasaoka T., Kimura I., Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacology 2004 4, article 18 2-s2.0-12944291304 10.1186/1471-2210-4-18 (Pubitemid 40177096)
8. Iso H., Date C., Wakai K., Fukui M., Tamakoshi A., Mori M., Motohashi Y., Tsuji I., Nakamura Y., Mikami H., Hashimoto S., Inaba Y., Hoshiyama Y., Suzuki H., Shimizu H., Toyoshima H., Tokudome S., Ito Y., Kikuchi S., Koizumi A., Kawamura T., Watanabe Y., Miki T., Sakata K., Nose T., Hayakawa N., Yoshimura T., Fukuda K., Okamoto N., Shio H., Ohno Y., Kitagawa T., Kuroki T., Tajima K., The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Annals of Internal Medicine 2006 144 8 554 562 2-s2.0-33645977193 (Pubitemid 46768144)
9. Wolfram S., Raederstorff D., Preller M., Wang Y., Teixeira S. R., Riegger C., Weber P., Epigallocatechin gallate supplementation alleviates diabetes in rodents. Journal of Nutrition 2006 136 10 2512 2518 2-s2.0-33749456308 (Pubitemid 44521606)
10. International Diabetes Federation, IDF Diabetes Atlas 2011 5th Brussels, Belgium International Diabetes Federation. http://www.idf.org/diabetesatlas
11. Aronson D., Fisman E. Z., Tenenbaum A., Hyperglycemia and the pathobiology of diabetic complications,. Cardiovascular Diabetology: Clinical, Metabolic and Inflammatory Facets 2008 Basel, Switzerland Advances in Cardiology
12. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Journal of Diabetes Care 2010 33 supplement 1 S62 S69
13. Tesfaye S., Gill G., Chronic diabetic complications in Africa. African Journal of Diabetes Medicine 2011 9 4 8
14. Xu Y., He Z., King G. L., Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications. Current Diabetes Reports 2005 5 2 91 97 2-s2.0-20444479826 (Pubitemid 40823492)
15. Chintan A. P., Nimish L. P., Nayana B., Bhavna M., Mahendra G., Hardik T., Cardiovascular complication of diabetes mellitus. Journal of Applied Pharmaceutical Science 2011 4 1 6
16. Maritim A. C., Sanders R. A., Watkins J. B., Diabetes, oxidative stress, and antioxidants: a review. Journal of Biochemical and Molecular Toxicology 2003 17 1 24 38 2-s2.0-0037253073 10.1002/jbt.10058 (Pubitemid 36410972)
17. Ahmed R., The physiological and biochemical effects of diabetes on the balance between oxidative stress and antioxidant defense system. Medical Journal of Islamic World Academy of Sciences 2005 15 31 42
18. Goycheva P., Gadjeva V., Popov B., Oxidative stress and its complications in diabetes mellitus. Trakia Journal of Sciences 2006 4 1 8
19. Selvaraju V., Joshi M., Suresh S., Sanchez J. A., Maulik N., Maulik G., Diabetes, oxidative stress, molecular mechanism and cardiovascular disease-an overview. Toxicology Mechanisms and Methods 2012 22 5 330 335 10.3109/15376516.2012.666648
20. Locatelli F., Canaud B., Eckardt K. U., Stenvinkel P., Wanner C., Zoccali C., Oxidative stress in end-stage renal disease: an emerging treat to patient outcome. Nephrology Dialysis Transplantation 2003 18 7 1272 1280 2-s2.0-0038353176 (Pubitemid 36826946)
21. Samouilidou E. C., Grapsa E. J., Kakavas I., Lagouranis A., Agrogiannis B., Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis. International Urology and Nephrology 2003 35 3 393 397 2-s2.0-3042805321 10.1023/B:UROL.0000022846.83505.3f (Pubitemid 39127558)
22. Ritz E., Diabetic nephropathy. Saudi Journal of Kidney Diseases and Transplantation 2006 17 4 481 490 2-s2.0-34248505275
23. Tang S. C. W., Diabetic nephropathy: a global and growing threat. Hong Kong Medical Journal 2010 16 4 244 245 2-s2.0-77957731940
24. Burns K. D., Angiotensin II and its receptors in the diabetic kidney. American Journal of Kidney Diseases 2000 36 3 449 467 2-s2.0-0033858529
25. Xue C., Siragy H. M., Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor. Hypertension 2005 46 3 584 590 2-s2.0-25644434249 10.1161/01.HYP.0000175814.18550.c0 (Pubitemid 41379384)
26. Bataller R., Sancho-Bru P., Ginès P., Brenner D. A., Liver fibrogenesis: a new role for the renin-angiotensin system. Antioxidants and Redox Signaling 2005 7 9-10 1346 1355 2-s2.0-24144432258 10.1089/ars.2005.7.1346 (Pubitemid 41232532)
27. 2 receptor in the kidney: role in health and disease. Seminars in Nephrology 2004 24 2 93 100 2-s2.0-1642331454 10.1016/j.semnephrol.2003.11.009 (Pubitemid 38387850)
28. Gnudi L., Goldsmith D., Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetes. F1000 Medicine Reports 2010 2 1, article 18 2-s2.0-77955058990 10.3410/M2-18
29. National Research Counci, lInstitute for Laboratory Animal Research, Commission on Life Sciences, Guide for the Care and Use of Animals 1996 Washington, DC, USA The National Academies Press
30. Drobiova H., Thomson M., Al-Qattan K., Peltonen-Shalaby R., Al-Amin Z., Ali M., Garlic increases antioxidant levels in diabetic and hypertensive rats determined by a modified peroxidase method. Evidence-based Complementary and Alternative Medicine 2011 2011 8 2-s2.0-79251570850 10.1093/ecam/nep011 703049
31. Murphy T. J., Alexander R. W., Griendling K. K., Runge M. S., Bernstein K. E., Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 1991 351 6323 233 236 2-s2.0-0025758883 10.1038/351233a0 (Pubitemid 21896571)
32. 1 receptor isoforms in the kidneys of the Sprague-Dawley rat and the desert rodent Meriones Crassus. Journal of Veterinary Medicine Series C 2006 35 2 130 138 2-s2.0-33644945517 10.1111/j.1439-0264.2005.00649.x
33. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 1976 72 1-2 248 254 2-s2.0-0017184389
34. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 2-s2.0-0018384650 (Pubitemid 9194347)
35. Abei H., Catalase in the Method of Enzymatic Analysis 1974 2 New York, NY, USA Academic Press
36. Al-Amin Z. M., Thomson M., Al-Qattan K. K., Ali M., Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. British Journal of Nutrition 2006 96 4 660 666 2-s2.0-33947274715 10.1079/BJN20061849 (Pubitemid 46470189)
37. Thomson M., Al-Amin Z. M., Al-Qattan K. K., Shaban L. H., Ali M., Anti-diabetic and hypolipidaemic properties of garlic (Allium sativum) in streptozotocin-induced diabetic rats. International Journal of Diabetes and Metabolism 2007 15 3 108 115 2-s2.0-63449112936
38. Anandh Babu P. V., Sabitha K. E., Shyamaladevi C. S., Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats. Clinical and Experimental Pharmacology and Physiology 2006 33 12 1184 1189 2-s2.0-33845528139 10.1111/j.1440-1681.2006. 04509.x (Pubitemid 44923906)
39. Anderson R. A., Polansky M. M., Tea enhances insulin activity. Journal of Agricultural and Food Chemistry 2002 50 24 7182 7186 2-s2.0-0037145882 10.1021/jf020514c (Pubitemid 35332804)
40. Wu L. Y., Juan C. C., Ho L. T., Hsu Y. P., Hwang L. S., Effect of green tea supplementation on insulin sensitivity in sprague-dawley rats. Journal of Agricultural and Food Chemistry 2004 52 3 643 648 2-s2.0-0842284665
41. Ortsater H., Grankvist N., Wolfram S., Kuehn N., Sjoholm A., Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice. Nutrition and Metabolism 2012 9 11 17
42. Wu L. Y., Juan C. C., Hwang L. S., Hsu Y. P., Ho P. H., Ho L. T., Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. European Journal of Nutrition 2004 43 2 116 124 2-s2.0-2442686532 10.1007/s00394-004-0450-x (Pubitemid 38661225)
43. Kobayashi Y., Suzuki M., Satsu H., Arai S., Hara Y., Suzuki K., Miyamoto Y., Shimizu M., Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism. Journal of Agricultural and Food Chemistry 2000 48 11 5618 5623 2-s2.0-0033662213 10.1021/jf0006832
44. Yasui K., Tanabe H., Okada N., Fukutomi R., Ishigami Y., Isemura M., Effects of catechin-rich green tea on gene expression of gluconeogenic enzymes in rat hepatoma H4IIE cells. Biomedical Research 2010 31 3 183 189 2-s2.0-77954729890 10.2220/biomedres.31.183
45. Yokozawa T., Nakagawa T., Kitani K., Antioxidative activity of green tea polyphenol in cholesterol-fed rats. Journal of Agricultural and Food Chemistry 2002 50 12 3549 3552 2-s2.0-0037023968 10.1021/jf020029h (Pubitemid 34579289)
46. Ojo O. O., Ladeji O., Nadro M. S., Studies of the antioxidative effects of green and black tea (Camellia sinensis) extracts in rats. Journal of Medicinal Food 2007 10 2 345 349 2-s2.0-34547114491 10.1089/jmf.2006.211 (Pubitemid 47105681)
47. Hininger-Favier I., Benaraba R., Coves S., Anderson R. A., Roussel A. M., Green tea extract decreases oxidative stress and improves insulin sensitivity in an animal model of insulin resistance, the fructose-fed rat. Journal of the American College of Nutrition 2009 28 4 355 361 2-s2.0-77951597510
48. Roghani M., Baluchnejadmojarad T., Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats. Pathophysiology 2010 17 1 55 59 2-s2.0-73649149403 10.1016/j.pathophys.2009.07.004
49. Yokozawa T., Nakagawa T., Oya T., Okubo T., Juneja L. R., Green tea polyphenols and dietary fibre protect against kidney damage in rats with diabetic nephropathy. Journal of Pharmacy and Pharmacology 2005 57 6 773 780 2-s2.0-18844457630 10.1211/0022357056154 (Pubitemid 40694886)
50. 1 receptor in adrenal and renal tissues of streptozotocin-induced diabetic rats. Inflammopharmacology. In press 10.1007/s10787-012-0139-3
51. 1 receptors in the kidney: focus on renomedullary interstitial cells. Hypertension Research 1997 20 4 233 250 2-s2.0-0031457833
52. 1 receptor upregulation causes increased stimulation of sodium transporters and hypertension. American Journal of Physiology 2008 295 3 F698 F706 2-s2.0-54449095044 10.1152/ajprenal.90308.2008
53. Sharma K., Jin Y., Guo J., Ziyadeh F. N., Neutralization of TGF- β by anti-TGF- β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996 45 4 522 530 2-s2.0-0029924637
54. Elosta A., Ghous T., Ahmed N., Natural products as anti-glycation agents: possible therapeutic potential for diabetic complications. Current Diabetes Reviews 2012 8 2 92 108
55. 1 receptor blockade prevent fatty liver and fibrosis in obese zucker rats. Obesity 2008 16 4 770 776 2-s2.0-41549156590 10.1038/oby.2007.114 (Pubitemid 351465631)